Related Experiment Video

Updated: Aug 11, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
11:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

Modulation of the activation of Stat1 by the interferon-gamma receptor complex

Christopher D Krause1, Wen He, Sergei Kotenko

  • 1Department of Molecular Genetics, Microbiology and Immunology, Robert Wood Johnson Medical School, The University of Medicine and Dentistry of New Jersey, 675 Hoes Lane West, Piscataway, 08855, USA.

Cell Research
|February 10, 2006
PubMed

Insights

Interferon-gamma (IFN-gamma) receptor chain expression regulates Stat1 activation. Modifying receptor chains alters Stat1 activation rates, offering potential pharmacological benefits for IFN-gamma signaling pathways.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Signaling

Background:

  • Interferon-gamma (IFN-gamma) signaling through its receptor complex activates Stat1, a key transcription factor for IFN-gamma-induced genes.
  • Stat1 activation mediates apoptosis, while its absence promotes proliferation in response to IFN-gamma.
  • Modulating Stat1 activation holds potential pharmacological value.

Purpose of the Study:

  • To investigate the impact of altering interferon-gamma receptor (IFN-gammaR) chain expression on Stat1 activation rates.
  • To explore the feasibility of modifying Stat1 activation kinetics for therapeutic purposes.

Main Methods:

  • Overexpression of IFN-gamma receptor 1 (IFN-gammaR1) and IFN-gamma receptor 2 (IFN-gammaR2) chains in HeLa cells.
  • Analysis of Stat1 activation rates in various cell lines (HeLa, Raji, monocytic) with differing receptor expression levels.
  • Utilizing a chimeric IFN-gammaR2 chain lacking Jak2 binding capability to inhibit Stat1 activation.

Main Results:

  • Overexpressing either IFN-gammaR1 or IFN-gammaR2 chains altered Stat1 activation rates in HeLa cells.
  • Cell lines with varying IFN-gammaR2 expression levels exhibited corresponding Stat1 activation kinetics.
  • Overexpression of a non-Jak2 binding chimeric IFN-gammaR2 or IFN-gammaR1 inhibited rapid Stat1 activation.
  • Data support a model where increased Jak2 recruitment accelerates Stat1 activation.

Conclusions:

  • The rate of Stat1 activation by IFN-gamma can be modulated by regulating either IFN-gammaR1 or IFN-gammaR2 chain expression.
  • Pharmacological agents targeting receptor chain expression could potentially modify IFN-gamma receptor signal transduction.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...